Buy & Sell Inovio Pharmaceuticals Inc (INO) – Inovio Pharmaceuticals Inc Price Today
Aura AI Summary
Key Stats
- $107.78MMarket Cap
- HealthSector
- -39.66%3M Drawdown
- $78.79MEnterprise Value
- -Dividend Yield
- 58% Buy | 42% SellTrading Activity
- 40 daysTypical Hold Time
Inovio Pharmaceuticals Inc (INO) is currently valued at a market capitalization of $107.78M, with an enterprise value of $78.79M. Over the past 52 weeks, Inovio Pharmaceuticals Inc has traded between a low of $1.05 and a high of $2.87, highlighting its annual price range. Over the past three months, Inovio Pharmaceuticals Inc has recorded a drawdown of -39.66%, reflecting recent price volatility. On average, investors hold Inovio Pharmaceuticals Inc for approximately 40 days, indicating typical investor behavior on the platform.
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Most Recent News
Virginia passes new zoning laws to expand placement of manufactured homes statewide from July 1, 2026.
Virginia Governor Abigail Spanberger signed House Bill 655 and Senate Bill 346, reforming zoning laws to allow manufactured homes in areas where site-built homes are permitted. The laws prevent local governments from imposing stricter rules on manufa...

Nokia shares surge 140% in 2025 after Nvidia's $1B investment boosts telecom growth.
Nokia's shares have risen over 140% year-to-date in 2025, reaching about $16 by late May. This surge followed Nvidia's $1 billion investment in October 2025, acquiring a 3% stake at $6.01 per share. The company's optical network infrastructure revenu...

Pan American Silver hits record Q1 cash flow amid strong silver market and analyst buy ratings.
Pan American Silver (PAAS) reported a record first-quarter free cash flow of $488 million and holds $1.8 billion in cash and short-term investments, positioning it well for capital growth. The company benefits from a robust silver market marked by a ...
